19.03.2026 /
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect
Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
First “protein map” of neurons that initiate pain
